BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15903150)

  • 1. Neurocognitive deficits in cocaine users: a quantitative review of the evidence.
    Jovanovski D; Erb S; Zakzanis KK
    J Clin Exp Neuropsychol; 2005 Feb; 27(2):189-204. PubMed ID: 15903150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data.
    Schoechlin C; Engel RR
    Arch Clin Neuropsychol; 2005 Aug; 20(6):727-44. PubMed ID: 15953706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
    Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
    Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive dysfunction in chronic cocaine users: an exploratory study.
    Madoz-Gúrpide A; Blasco-Fontecilla H; Baca-García E; Ochoa-Mangado E
    Drug Alcohol Depend; 2011 Aug; 117(1):55-8. PubMed ID: 21277707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.
    Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ
    Neuropsychology; 2005 Jul; 19(4):520-31. PubMed ID: 16060827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insomnia and daytime cognitive performance: a meta-analysis.
    Fortier-Brochu E; Beaulieu-Bonneau S; Ivers H; Morin CM
    Sleep Med Rev; 2012 Feb; 16(1):83-94. PubMed ID: 21636297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Executive functioning in unipolar depression: a review].
    Fossati P; Ergis AM; Allilaire JF
    Encephale; 2002; 28(2):97-107. PubMed ID: 11972136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention and executive functions in remitted major depression patients.
    Paelecke-Habermann Y; Pohl J; Leplow B
    J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive functions in euthymic bipolar patients.
    Jamrozinski K; Gruber O; Kemmer C; Falkai P; Scherk H
    Acta Psychiatr Scand; 2009 May; 119(5):365-74. PubMed ID: 19076115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
    Dickinson D; Ramsey ME; Gold JM
    Arch Gen Psychiatry; 2007 May; 64(5):532-42. PubMed ID: 17485605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gender differences in the neurocognitive components of depression].
    Sárosi A; Gonda X; Balogh G; Székely A; Sasvári M; Faludi G
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):191-9. PubMed ID: 19213198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function.
    DeRoche K; Welsh M
    Dev Neuropsychol; 2008; 33(4):474-504. PubMed ID: 18568900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.